A Phase II Trial of Pevonedistat and Docetaxel in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer.
Saved in:
| Title: | A Phase II Trial of Pevonedistat and Docetaxel in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer. |
|---|---|
| Authors: | Qin A; University of Michigan Rogel Cancer Center, Ann Arbor, MI. Electronic address: qina@med.umich.edu., Wells L; University of Michigan Rogel Cancer Center, Ann Arbor, MI., Malhotra B; Covenant Cancer Center, Saginaw, MI., Gadgeel S; Henry Ford Cancer Institute, Detroit, MI., Schneider BJ; University of Michigan Rogel Cancer Center, Ann Arbor, MI., Ramnath N; University of Michigan Rogel Cancer Center, Ann Arbor, MI; VA Ann Arbor Healthcare System, Ann Arbor, MI., Rice JD; Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor, MI., Kalemkerian GP; University of Michigan Rogel Cancer Center, Ann Arbor, MI. |
| Source: | Clinical lung cancer [Clin Lung Cancer] 2024 Mar; Vol. 25 (2), pp. 128-134. Date of Electronic Publication: 2023 Oct 26. |
| Publication Type: | Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 100893225 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0690 (Electronic) Linking ISSN: 15257304 NLM ISO Abbreviation: Clin Lung Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1938-0690 |
|---|---|
| DOI: | 10.1016/j.cllc.2023.10.011 |
